benzinga.comIncyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses5 days ago
prnewswire.comSpecialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions9 days ago
benzinga.comAbeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapyabout 2 months ago
benzinga.comStocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday?about 2 months ago
cnbc.comStocks making the biggest moves premarket: Affirm, Netflix, Incyte, Norwegian Cruise Line & more3 months ago
CashuIncyte's INCA033989: A Promising Breakthrough for Myeloproliferative Neoplasms Treatment2 days ago
CashuIncyte Corporation (INCY): Analyst Insights Amid Biopharmaceutical Industry Uncertainties15 days ago